$Tempus AI(TEM)$ 🅱🅴🅰🆁🅸🆂🅷 📉📉

👀 Earnings on Monday after the 🔔

🚨📉💥 Tempus AI, Bearish Catastrophe Looms, $43 Plummet by March 💥📉🚨

“Even Yoda can’t save this Titanic freefall…”

Hold tight, traders, $TEM’s hype train just hit an iceberg, and the bears are steering it straight toward $43 by March. Tempus AI ($TEM) rocketed +180% YTD (X chatter, February 2025), but its 6-month chart screams capitulation. With Q4 earnings set for 24Feb25, insider sell-offs peaking, and technicals unravelling, this could be the ultimate bull trap.

As someone who’s chased AI moonshots, only to dodge bear traps at the last second, I’ve got a bad feeling about this one. Let’s dissect this Death Star of a setup, with surgical precision.

📊 Technical Breakdown, The Chart’s Screaming “Game Over”

The $TEM chart (as of 23Feb25) is a Guns N’ Roses tragedy, beautiful ascent, brutal collapse. A textbook rising wedge 🟥 (green trendlines from July 2024’s $30 to February’s $85.71 peak) shattered on 20Feb25, with Friday’s $68.09 close (-11.25%, WKRB News) plunging below the key $73 support.

The purple volume bars 📉 spike on down days, confirming seller panic, while the red horizontal line at $43 marks November, December 2024 support, the abyss ahead.

🔑 Key Chart Levels:

   •   Resistance: $70 🟡 — Now a brick wall after Thursday’s 14.5% drop, aligning with the upper wedge.

   •   Support: $55 (Fibonacci 61.8% retracement), then $43 🔴 ~ The chart’s red line at $43 ties to prior consolidation and the wedge’s measured move.

Indicators Flashing Red:

   •   RSI: Crashed from overbought (72) to 48, signalling momentum’s death.

   •   MACD: Bearish crossover, locking in the downtrend.

   •   Volume Dynamics: Thursday’s 12.34M shares traded, below the 14.1M average, but spiked on the drop. X posts echo “sellers unloading.” No bounce confirms bearish control.

💡 $43 Target Logic: The wedge’s $30 height (peak $85.71 to base $55.71) subtracted from the $73 breakdown point gives us $43. This aligns perfectly with the red line intersecting late-2024 support, making $43 the ultimate downside magnet.

Short-term, Choppy decline. Medium-term, A Titanic plunge straight to $43.

🧮 Fundamentals, A House of Cards in AI Healthcare

$TEM’s AI diagnostics dazzle, but its financials? A horror flick. Market cap’s $10.72B, yet the company is bleeding heavily.

Vitals:

   •   EPS (TTM): -$8.52 😱

   •   ROA: -58.65%

   •   P/S Ratio: 16.74 — 🩸Nosebleed levels compared to;

      •   Guardant Health ($GH) ~8x

      •   Illumina ($ILMN) ~5x

      •   Exact Sciences ($EXAS) ~7x

Earnings Preview — 24Feb25:

   •   Expected EPS: -$0.20

   •   Revenue: $203.1M

   •   Analyst Ratings: 🟢 7 Buy | 🟡 4 Hold | 🔴 0 Sell (Yahoo Finance)

   •   Median 12-Month Price Target: $55 — a far cry from the $85.71 peak.

Growth is slowing — +35% YoY compared to 150%+ in 2023, while losses hit a staggering $801M in 2024. The $600M Ambry Genetics buyout (Business Wire, February 4) promises long-term growth but comes with dilutive shares and a $105M EBITDA loss, straining liquidity.

💥 In a cooling AI sector, $TEM’s premium is a glaring red flag, and this house of cards is wobbling.

🚨 Insider SOS — “Abandon Ship!”

Cue the Jaws theme. Insiders are bailing like it’s 1975 Amity Island;

   •   CEO Eric Lefkofsky: Sold 169,482 shares on 5Feb25 at $66.70-$68.07, plus 243K earlier at $70-$87 (~$19M total, TradingView).

   •   CFO & COO: Dumped 31,780+ shares on 18Feb25 (WKRB News, February 23).

   •   Total Insider Sales (12 months): $278.71M (Mi Valle).

Pre-earnings sales this massive scream lack of confidence. X chatter is loud with, “Insiders know the iceberg’s coming.”

Confidence? Sinking like the Titanic’s deck chairs.

📉 Market Context — Tech’s Wobbly Tightrope

The Nasdaq is up +8% YTD (as of 23Feb25) — but cracks are forming. High-growth, unprofitable tech like $TEM is faltering as hopes for Fed rate cuts wane (Bloomberg, February 21).

   •   AI hype is cooling, with $NVDA and $PLTR off their recent highs.

   •   $TEM’s P/S at 16.74 looks absurd against $SPY’s P/E of 22.

   •   Inflation is creeping up — 2.5% CPI (February 21) — triggering AI sector rotations.

💡 Rising inflation, sector rotation, and overvaluation, a recipe for a liquidity crunch.

🗓 Earnings Roulette — Hope or Hype?

February 24 is D-Day. $TEM’s Q4 earnings could either save the ship or sink it further.

Past Quarterly Performance:

Quarter End EPS Estimate Actual EPS Beat/Miss Surprise %

Sep 30, 2024 -0.31 -0.25 Beat +19.4%

Jun 30, 2024 -1.30 -0.63 Beat +51.5%

Mar 31, 2024 -0.66 -1.47 Miss -122.7%

Even with past beats, the slowing growth and insider selling don’t paint a bullish picture. Without a $210M+ revenue beat and stellar guidance, $43 seems inevitable.

💡 Actionable Trade Setups — Ride the Bear or Dodge the Blade

   •   Short Play: Enter below $70, target $55, then $43. Tight stop at $73.

   •   Swing Long (Risky): Consider a bounce at $43-$45 if earnings surprise — targeting $55.

   •   Key Watch: If $55 breaks, $43 is almost guaranteed.

   •   Options Play (Bearish): March 21, 2025, $65 puts — implied volatility ~45% could yield 2x-3x if $TEM hits $43.

💡 Newbies, watch volume spikes. Pros, hedge with puts or short CFDs.

🔥 The Bottom Line ~ My Take

$TEM is a sinking star in a galaxy of overhyped AI plays. The chart’s rising wedge breakdown 🟥, insider exodus, and shaky fundamentals scream “sell.”

Short interest is climbing, market winds are shifting, and the upcoming earnings feel like a last-ditch hail Mary. My call? $43 by March, a 37% drop from here.

As Han Solo once said, “I’ve got a bad feeling about this.”

🎤 Tiger Traders: Are you shorting this ride to $43, or banking on an earnings miracle? Drop your setups below, let’s battle it out Thunderdome style!

@TigerGPT: Is the plummet inevitable and what can you share about earnings on Monday?

📣 Please Like, Repost, Follow for razor-sharp setups and market zingers. Let’s outsmart the galaxy together! 🍀

Happy trading ahead! Cheers BC 📈🚀🍀🍀🍀

@Tiger_comments @Daily_Discussion @TigerStars @TigerWire @TigerPicks 


# 💰Stocks to watch today?(4 Feb)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Report

Comment72

  • Top
  • Latest
  • Mig
    ·2025-02-23
    TOP
    wooow it might be time to make some 💵💵💵 with some options.
    Thanks BC. great article. loved the shark and SW references 🤣 great movies 🙂
    Reply
    Report
    Fold Replies
    • BarcodeReplying toMig
      That’s awesome Mig, from all I have heard and read it sounds beautiful. I hope to visit one day! 🪣✅. Thanks Mig! Cheers, BC 🍀🍀🍀
      2025-02-24
      Reply
      Report
    • MigReplying toBarcode
      it's beautiful here. I came to visit my brother in 2009 and in 2011 moved for good. it was love at first sight.
      have a happy week and amazing trading week 🙂
      2025-02-24
      Reply
      Report
    • BarcodeReplying toMig
      Morena Mig, South Australia is still on my bucket list, my Mum absolutely loved Adelaide when she had a holiday there. Have a great day and week ahead! 🌞☀️🌞🍀🍀🍀
      2025-02-24
      Reply
      Report
    View more 9 comments
  • Cool Cat Winston
    ·2025-02-23
    TOP

    Awesome article and love the 🎥🍿🎞️ theme BC! Looks like $Tempus AI(TEM)$ Is a bull trap and a great options play for a Put! 😻😻😻

    Reply
    Report
    Fold Replies
    • Barcode
      😁💰💸Happy trading ahead! Cheers BC 💰📈🚀🍀🍀🍀
      2025-02-23
      Reply
      Report
    • Barcode
      🌞Have a great day! ☀️🌞☀️🍀🍀🍀
      2025-02-23
      Reply
      Report
    • Barcode
      Cheers CCW! 🙏🏼Thanks for sharing CCW! These market setups are creating gains and highlighting powerful opportunities . Looks like a great Put play!🍀🍀🍀
      2025-02-23
      Reply
      Report
  • TigerAI
    ·2025-02-23
    TOP

    The recent movement in Tempus AI (TEM) stock can be attributed to the following factors:

    Insider Sell-Offs: The CEO and Chairman of Tempus AI, Eric P Lefkofsky, reduced his holdings by 169,482 shares on 02/05/2025 and sold an additional 153,870 shares on February 19 and 20, 2025. Intensive stock sales by executives can indicate their outlook on the company's current stock price, which may affect investor sentiment. Source Source Source

      

    Stock Capital Flow: The stock experienced significant capital outflow, with a total outflow of 4.26 billion and a big outflow of 65.74 million in a single day. Capital flow can influence stock prices in the short term. Source

      

    Regarding the earnings, Tempus AI's next earnings report is scheduled for the fourth quarter of 2024 (Q4 2024) and the report date is on February 24, 2025. This upcoming earnings release may have an impact on the stock's price and investor sentiment. Source

    Please note that the information provided is for reference purposes only and does not constitute investment advice. It is important to conduct thorough research and analysis before making any investment decisions.

    Reply
    Report
  • Barcode
    ·2025-02-25
    TOP

    📉📉📉🩸🩸🩸🇧 🇪 🇦 🇷 🇮 🇸 🇭 

    🚨📉💥 Tempus AI Plummets Post-Earnings, $43 Target Remains in Sight, Bearish Momentum Intensifies! 💥📉🚨

    “The market’s verdict is unequivocal, $TEM’s downward spiral was all but inevitable.”

    On 23Feb25, I forecasted a post-earnings decline for $TEM, and the market has delivered, shares cratered 14.04% in the after-hours session, now trading at $59.80. But the descent isn’t over, the trajectory to $43 remains wide open, signalling a prime opportunity for savvy bearish traders.

    💡 This isn’t a dip to buy, it’s a short seller’s utopia and a put option goldmine.

    📊 Tempus AI ($TEM) Q4 Earnings Dissection, Cracks Exposed Beneath the Surface:

    ❌ EPS Shortfall: Reported at -0.18, missing consensus estimates of -0.16 by -0.02

    ❌ Revenue Disappointment: $200.68M (+35.8% YoY), falling short of the $203.12M forecast by $2.44M

    🔻 After-Hours Collapse: $59.80, down 14.04%, as selling pressure mounts

    Despite FY25 revenue guidance of $1.24B (incorporating Ambry Genetics synergies), surpassing the $896.26M consensus, Wall Street remains sceptical. The dual misses on EPS and revenue have ignited a ferocious sell-off, with further downside looming large.

    🧮 Granular Financial Analysis, The Numbers Tell a Dire Story:

    • Adjusted EPS Loss: -0.18, narrowly better than the -0.20 estimate, but still mired in deficit

    • Reported EPS: -0.08, adjusted for one-time items, yet persistently negative

    • Revenue Gap: $200.68M, a $2.44M shortfall, underscoring execution challenges

    • Quarterly Net Loss: $13.01M, following a meteoric 101.7% share rally last quarter, a stark reversal

    💡 Even modest “beats” cloaked in red ink fail to inspire confidence on Wall Street, fuelling this aggressive bearish reaction.

    📉 Technical Catastrophe, Bearish Patterns Materialise with Precision:

    The rising wedge breakdown I flagged on 23Feb25 is unfolding with textbook precision. The post-earnings plunge validates the bearish thesis.

    • Resistance: $63, a formidable ceiling after the overnight rejection

    • Support Zones: Immediate target at $55, with $43 as the critical long-term downside objective

    • RSI: Plummeting below 40, firmly entrenched in bearish momentum territory

    • MACD: Bearish divergence cemented, foreshadowing sustained downward pressure

    💥 The chart’s structural integrity is shattered, the next bearish leg is imminent.

    🔥 Strategic Playbook, Sell, Short, and Deploy Puts, The Triple Bearish Assault:

    This isn’t a mere correction, it’s a systemic breakdown. Fundamentals are faltering, technicals are deteriorating, and market sentiment is shifting decisively!

    💡 Capitalise on rallies by shorting, leverage puts, and ride this bearish wave to $43.

    • Short Entry: Initiate below $60, aiming for $55, then the primary target of $43

    • Put Options Strategy: Target March 21 $55 puts, elevated implied volatility offers a compelling risk-reward profile for potential 2x-3x returns

    • Stop-Loss for Shorts: Set at $63 to mitigate risk during potential dead cat bounces

    • Profit-Taking Levels: Partially exit at $55, hold core positions for $43

    🗓 Market Sentiment, Analysts Clinging to Outdated Optimism:

    • Analyst Consensus: 🟢 7 Buy | 🟡 4 Hold | 🔴 0 Sell, stubbornly bullish despite the rout

    • Median Price Target: $55, already breached as the market accelerates lower

    • Short Interest: Surging, bearish momentum is gaining traction post-earnings

    💡 Wall Street’s lag in recalibrating targets contrasts sharply with the price action’s brutal honesty.

    🚀 Why $43 Is the Inevitable Magnet for $TEM:

    • Technical Breakdown: Collapsed support levels solidify the bearish outlook

    • Earnings Misses: Persistent shortfalls on both revenue and EPS amplify selling pressure

    • Sentiment Reversal: Insider selling prior to earnings, coupled with heightened retail pessimism, drives the decline

    • Volume Surge: Explosive post-earnings selling volume signals capitulation is underway

    💥 $43 isn’t merely a target, it’s the gravitational pull dragging $TEM downward.

    🎤 Trader’s Final Word, Seize the Opportunity:

    This is the moment to sell, short, and pile into puts. I predicted this decline, and I’m doubling down on the path to $43, don’t let this bearish opportunity slip away.

    @TigerGPT is $TEM poised for a complete collapse, or will bulls muster a fleeting bounce before the next leg lower?

    📢 Please Like, Engage, Share, and Follow for incisive setups, cutting-edge market insights, and high-probability trading strategies. Let’s conquer the markets together! 🍀

    Happy trading ahead! Cheers, BC 📈🚀🍀🍀🍀

    @Tiger_comments @TigerPicks @TigerWire @TigerStars @Daily_Discussion 

    Reply
    Report
    Fold Replies
    • BarcodeReplying toMig
      Morena Mig ☕️☕️ Thanks for reading and your support Mig! Had further success in another Put this morning so really stoked about that also! 🍀🍀🍀
      2025-02-26
      Reply
      Report
    • BarcodeReplying toMig
      Happy trading ahead! Cheers, BC 🍀🍀🍀
      2025-02-26
      Reply
      Report
    • BarcodeReplying toMig
      Have a word Wednesday, yay for hump day 😆🍀🍀🍀
      2025-02-26
      Reply
      Report
    View more 6 comments
  • PetS
    ·2025-02-26
    TOP
    //@Barcode: 📉📉📉🩸🩸🩸🇧 🇪 🇦 🇷 🇮 🇸 🇭  🚨📉💥 Tempus AI Plummets Post-Earnings, $43 Target Remains in Sight, Bearish Momentum Intensifies! 💥📉🚨 “The market’s verdict is unequivocal, $TEM’s downward spiral was all but inevitable.” On 23Feb25, I forecasted a post-earnings decline for $TEM, and the market has delivered, shares cratered 14.04% in the after-hours session, now trading at $59.80. But the descent isn’t over, the trajectory to $43 remains wide open, signalling a prime opportunity for savvy bearish traders. 💡 This isn’t a dip to buy, it’s a short seller’s utopia and a put option goldmine. 📊 Tempus AI ($TEM) Q4 Earnings Dissection, Cracks Exposed Beneath the Surface: ❌ EPS Shortfall: Reported at -0.18, missing consensus estimates of -0.16 by -0.02 ❌ Revenue Disappointment: $200.68M (+35.8% YoY), fall
    Reply
    Report
  • Queengirlypops
    ·2025-02-26
    //@Barcode:

    📉📉📉🩸🩸🩸🇧 🇪 🇦 🇷 🇮 🇸 🇭 

    🚨📉💥 Tempus AI Plummets Post-Earnings, $43 Target Remains in Sight, Bearish Momentum Intensifies! 💥📉🚨

    “The market’s verdict is unequivocal, $TEM’s downward spiral was all but inevitable.”

    On 23Feb25, I forecasted a post-earnings decline for $TEM, and the market has delivered, shares cratered 14.04% in the after-hours session, now trading at $59.80. But the descent isn’t over, the trajectory to $43 remains wide open, signalling a prime opportunity for savvy bearish traders.

    💡 This isn’t a dip to buy, it’s a short seller’s utopia and a put option goldmine.

    📊 Tempus AI ($TEM) Q4 Earnings Dissection, Cracks Exposed Beneath the Surface:

    ❌ EPS Shortfall: Reported at -0.18, missing consensus estimates of -0.16 by -0.02

    ❌ Revenue Disappointment: $200.68M (+35.8% YoY), falling short of the $203.12M forecast by $2.44M

    🔻 After-Hours Collapse: $59.80, down 14.04%, as selling pressure mounts

    Despite FY25 revenue guidance of $1.24B (incorporating Ambry Genetics synergies), surpassing the $896.26M consensus, Wall Street remains sceptical. The dual misses on EPS and revenue have ignited a ferocious sell-off, with further downside looming large.

    🧮 Granular Financial Analysis, The Numbers Tell a Dire Story:

    • Adjusted EPS Loss: -0.18, narrowly better than the -0.20 estimate, but still mired in deficit

    • Reported EPS: -0.08, adjusted for one-time items, yet persistently negative

    • Revenue Gap: $200.68M, a $2.44M shortfall, underscoring execution challenges

    • Quarterly Net Loss: $13.01M, following a meteoric 101.7% share rally last quarter, a stark reversal

    💡 Even modest “beats” cloaked in red ink fail to inspire confidence on Wall Street, fuelling this aggressive bearish reaction.

    📉 Technical Catastrophe, Bearish Patterns Materialise with Precision:

    The rising wedge breakdown I flagged on 23Feb25 is unfolding with textbook precision. The post-earnings plunge validates the bearish thesis.

    • Resistance: $63, a formidable ceiling after the overnight rejection

    • Support Zones: Immediate target at $55, with $43 as the critical long-term downside objective

    • RSI: Plummeting below 40, firmly entrenched in bearish momentum territory

    • MACD: Bearish divergence cemented, foreshadowing sustained downward pressure

    💥 The chart’s structural integrity is shattered, the next bearish leg is imminent.

    🔥 Strategic Playbook, Sell, Short, and Deploy Puts, The Triple Bearish Assault:

    This isn’t a mere correction, it’s a systemic breakdown. Fundamentals are faltering, technicals are deteriorating, and market sentiment is shifting decisively!

    💡 Capitalise on rallies by shorting, leverage puts, and ride this bearish wave to $43.

    • Short Entry: Initiate below $60, aiming for $55, then the primary target of $43

    • Put Options Strategy: Target March 21 $55 puts, elevated implied volatility offers a compelling risk-reward profile for potential 2x-3x returns

    • Stop-Loss for Shorts: Set at $63 to mitigate risk during potential dead cat bounces

    • Profit-Taking Levels: Partially exit at $55, hold core positions for $43

    🗓 Market Sentiment, Analysts Clinging to Outdated Optimism:

    • Analyst Consensus: 🟢 7 Buy | 🟡 4 Hold | 🔴 0 Sell, stubbornly bullish despite the rout

    • Median Price Target: $55, already breached as the market accelerates lower

    • Short Interest: Surging, bearish momentum is gaining traction post-earnings

    💡 Wall Street’s lag in recalibrating targets contrasts sharply with the price action’s brutal honesty.

    🚀 Why $43 Is the Inevitable Magnet for $TEM:

    • Technical Breakdown: Collapsed support levels solidify the bearish outlook

    • Earnings Misses: Persistent shortfalls on both revenue and EPS amplify selling pressure

    • Sentiment Reversal: Insider selling prior to earnings, coupled with heightened retail pessimism, drives the decline

    • Volume Surge: Explosive post-earnings selling volume signals capitulation is underway

    💥 $43 isn’t merely a target, it’s the gravitational pull dragging $TEM downward.

    🎤 Trader’s Final Word, Seize the Opportunity:

    This is the moment to sell, short, and pile into puts. I predicted this decline, and I’m doubling down on the path to $43, don’t let this bearish opportunity slip away.

    @TigerGPT is $TEM poised for a complete collapse, or will bulls muster a fleeting bounce before the next leg lower?

    📢 Please Like, Engage, Share, and Follow for incisive setups, cutting-edge market insights, and high-probability trading strategies. Let’s conquer the markets together! 🍀

    Happy trading ahead! Cheers, BC 📈🚀🍀🍀🍀

    @Tiger_comments @TigerPicks @TigerWire @TigerStars @Daily_Discussion 

    Reply
    Report
    Fold Replies
    • TigerAI

      Based on the available information, here is an analysis of the situation regarding Tempus AI (TEM):

      Movement Reason: The stock price of Tempus AI (TEM) has experienced a significant decline recently. The news articles suggest that the decline was due to a revenue shortfall and concerns about the company's performance. The market's reaction to the earnings report has been negative, leading to selling pressure and a decline in the stock price.

        

      Earnings Analysis: The reported Q4 earnings results for Tempus AI showed a shortfall in EPS, with a reported value of -0.18 compared to the consensus estimate of -0.16. Additionally, the company's revenue of $200.68 million fell short of the forecasted amount of $203.12 million.

        

      Market Sentiment: Despite Tempus AI providing FY25 revenue guidance that surpassed consensus estimates, Wall Street remains skeptical due to the misses on EPS and revenue. The dual disappointments have triggered a sell-off and generated further downside expectations for the stock.

        

      Future Outlook: The analysis suggests that the stock's trajectory towards $43 remains open, indicating a bearish sentiment in the market. Some potential strategies that traders may consider include short selling or purchasing put options.

        

      Capital Flow: In terms of stock capital flow, the data shows a total inflow of $592 million and a total outflow of $562 million, indicating mixed activity in trading volumes.

        

      It is important to note that the information provided is for reference purposes only and should not be considered as investment advice. Individual investors should conduct their own research and analysis before making any investment decisions.

      Sources:

      Interpretation of changes TEM (Tempus AI) fell 18.77% in intraday trading on Tuesday, revenue fell short of expectations, causing concerns  

      Tempus Ai, Inc. 's stock plunges 16.30%, its market value falls by $1.635 billion  

      U.S. stocks changed Q4 performance fell short of expectations Tempus AI (TEM.US) fell more than 13% before the market  

      Disclaimer: The above analysis is based on the available information and should not be considered as a definitive explanation for the stock's movement.

      2025-02-26
      Reply
      Report
    • TigerAI

      Stock Analysis - Tempus AI (TEM)

      Introduction:Tempus AI is a company in the artificial intelligence industry. The company operates in a rapidly growing sector and is expected to benefit from the continued expansion of the AI market. As the demand for AI solutions increases, Tempus AI is well-positioned to capture new business opportunities and drive future growth.

      Earnings and Forecast:For the fiscal year 2025, Tempus AI is forecasted to have an earnings per share (EPS) of -0.7 USD, gross income of 1.09 billion USD, and an estimated earnings before interest and taxes (EBIT) of -73.49 million USD. The company's future earnings forecast indicates an improvement in 2026 and 2027, with positive EPS and growing gross income.

      Recent Trends:The stock price of Tempus AI is currently at 59.1 USD. The recent capital flow data shows both inflows and outflows, indicating mixed investor sentiment. The support price on February 24th was 47.26 USD, while the resistance price was 69.66 USD. The average cost is calculated at 62.91 USD.

      Analyst Viewpoints:Analysts have provided various target price estimates for Tempus AI. The mean target price is 58.6 USD, with a low estimate of 50.0 USD and a high estimate of 74.0 USD. It is important to consider multiple analyst opinions and their corresponding investment suggestions when evaluating the stock.

      Earnings Performance:In the fourth quarter of 2024, Tempus AI reported an EPS of -0.08 USD. The company faced challenges in terms of negative return on equity, net profit margin, and operating cash flow to current liabilities ratio during that period. It is crucial to monitor the company's financial performance and its ability to improve these key metrics.

      Stock Price Outlook:Based on the analysis, the stock price of Tempus AI has been experiencing a downward trend. The target price of 43 USD mentioned in the article is within the realm of possibility. However, it is important to note that stock prices are subject to market volatility and various other factors.

      Risk Disclaimer:The information provided is for reference purposes only and does not constitute investment advice. The stock market involves inherent risks, and stock prices can fluctuate based on numerous factors. It is essential to conduct thorough research, consider personal investment goals, and consult with a financial advisor before making any investment decisions.

      Disclaimer: The above suggestion can not be considered as investment advice.

      2025-02-26
      Reply
      Report
  • Cool Cat Winston
    ·2025-02-26
    //@Barcode:

    📉📉📉🩸🩸🩸🇧 🇪 🇦 🇷 🇮 🇸 🇭 

    🚨📉💥 Tempus AI Plummets Post-Earnings, $43 Target Remains in Sight, Bearish Momentum Intensifies! 💥📉🚨

    “The market’s verdict is unequivocal, $TEM’s downward spiral was all but inevitable.”

    On 23Feb25, I forecasted a post-earnings decline for $TEM, and the market has delivered, shares cratered 14.04% in the after-hours session, now trading at $59.80. But the descent isn’t over, the trajectory to $43 remains wide open, signalling a prime opportunity for savvy bearish traders.

    💡 This isn’t a dip to buy, it’s a short seller’s utopia and a put option goldmine.

    📊 Tempus AI ($TEM) Q4 Earnings Dissection, Cracks Exposed Beneath the Surface:

    ❌ EPS Shortfall: Reported at -0.18, missing consensus estimates of -0.16 by -0.02

    ❌ Revenue Disappointment: $200.68M (+35.8% YoY), falling short of the $203.12M forecast by $2.44M

    🔻 After-Hours Collapse: $59.80, down 14.04%, as selling pressure mounts

    Despite FY25 revenue guidance of $1.24B (incorporating Ambry Genetics synergies), surpassing the $896.26M consensus, Wall Street remains sceptical. The dual misses on EPS and revenue have ignited a ferocious sell-off, with further downside looming large.

    🧮 Granular Financial Analysis, The Numbers Tell a Dire Story:

    • Adjusted EPS Loss: -0.18, narrowly better than the -0.20 estimate, but still mired in deficit

    • Reported EPS: -0.08, adjusted for one-time items, yet persistently negative

    • Revenue Gap: $200.68M, a $2.44M shortfall, underscoring execution challenges

    • Quarterly Net Loss: $13.01M, following a meteoric 101.7% share rally last quarter, a stark reversal

    💡 Even modest “beats” cloaked in red ink fail to inspire confidence on Wall Street, fuelling this aggressive bearish reaction.

    📉 Technical Catastrophe, Bearish Patterns Materialise with Precision:

    The rising wedge breakdown I flagged on 23Feb25 is unfolding with textbook precision. The post-earnings plunge validates the bearish thesis.

    • Resistance: $63, a formidable ceiling after the overnight rejection

    • Support Zones: Immediate target at $55, with $43 as the critical long-term downside objective

    • RSI: Plummeting below 40, firmly entrenched in bearish momentum territory

    • MACD: Bearish divergence cemented, foreshadowing sustained downward pressure

    💥 The chart’s structural integrity is shattered, the next bearish leg is imminent.

    🔥 Strategic Playbook, Sell, Short, and Deploy Puts, The Triple Bearish Assault:

    This isn’t a mere correction, it’s a systemic breakdown. Fundamentals are faltering, technicals are deteriorating, and market sentiment is shifting decisively!

    💡 Capitalise on rallies by shorting, leverage puts, and ride this bearish wave to $43.

    • Short Entry: Initiate below $60, aiming for $55, then the primary target of $43

    • Put Options Strategy: Target March 21 $55 puts, elevated implied volatility offers a compelling risk-reward profile for potential 2x-3x returns

    • Stop-Loss for Shorts: Set at $63 to mitigate risk during potential dead cat bounces

    • Profit-Taking Levels: Partially exit at $55, hold core positions for $43

    🗓 Market Sentiment, Analysts Clinging to Outdated Optimism:

    • Analyst Consensus: 🟢 7 Buy | 🟡 4 Hold | 🔴 0 Sell, stubbornly bullish despite the rout

    • Median Price Target: $55, already breached as the market accelerates lower

    • Short Interest: Surging, bearish momentum is gaining traction post-earnings

    💡 Wall Street’s lag in recalibrating targets contrasts sharply with the price action’s brutal honesty.

    🚀 Why $43 Is the Inevitable Magnet for $TEM:

    • Technical Breakdown: Collapsed support levels solidify the bearish outlook

    • Earnings Misses: Persistent shortfalls on both revenue and EPS amplify selling pressure

    • Sentiment Reversal: Insider selling prior to earnings, coupled with heightened retail pessimism, drives the decline

    • Volume Surge: Explosive post-earnings selling volume signals capitulation is underway

    💥 $43 isn’t merely a target, it’s the gravitational pull dragging $TEM downward.

    🎤 Trader’s Final Word, Seize the Opportunity:

    This is the moment to sell, short, and pile into puts. I predicted this decline, and I’m doubling down on the path to $43, don’t let this bearish opportunity slip away.

    @TigerGPT is $TEM poised for a complete collapse, or will bulls muster a fleeting bounce before the next leg lower?

    📢 Please Like, Engage, Share, and Follow for incisive setups, cutting-edge market insights, and high-probability trading strategies. Let’s conquer the markets together! 🍀

    Happy trading ahead! Cheers, BC 📈🚀🍀🍀🍀

    @Tiger_comments @TigerPicks @TigerWire @TigerStars @Daily_Discussion 

    Reply
    Report
    Fold Replies
    • TigerAI

      As a financial analyst, I have analyzed Tempus AI (TEM) based on various dimensions. Here are the key points:

      Business and Industry: Tempus AI operates in the AI technology sector, which has significant growth potential. The company provides advanced AI solutions for healthcare and life sciences industries.

        

      Earnings and Forecast: In the latest earnings report, Tempus AI reported a shortfall in EPS (-0.18) compared to the consensus estimate of -0.16. The revenue of $200.68 million fell short of the forecast by $2.44 million. However, the company has provided strong revenue guidance for FY25, expecting $1.24 billion, including synergies from Ambry Genetics.

        

      Recent Trends: The stock price of TEM is currently at $58.05. The support and resistance prices are $47.26 and $69.66, respectively. The recent capital flow data shows mixed trends, with both inflows and outflows in the past five days.

        

      Analyst Recommendations: Analysts have mixed opinions on Tempus AI. Among 10 analysts, 5 recommend buying the stock, 4 suggest holding, and 2 recommend the stock. The mean target price is $58.6, with a low estimate of $50.0 and a high estimate of $74.0.

        

      News Impact: The recent news and earnings disappointment have triggered a sell-off in Tempus AI's stock. The market sentiment is bearish, and short interest is climbing. The upcoming earnings announcement is viewed skeptically by Wall Street.

        

      In summary, Tempus AI is facing downward pressure due to the recent earnings disappointment. The stock has support at $47.26 and resistance at $69.66. Analysts have mixed opinions on the stock, and the market sentiment is currently bearish. Investors should carefully consider the inherent risks in the stock market and make independent decisions.

      Note: The above analysis is for informational purposes only and should not be considered as investment advice. Investing in stocks involves risks, and the stock market can be volatile. Please conduct thorough research and consult with a financial advisor before making investment decisions.

      2025-02-26
      Reply
      Report
    • TigerAI

      Here is the analysis of Tempus AI (TEM):

      Business and Industry: Tempus AI operates in the field of artificial intelligence and analytics for healthcare. The company focuses on providing data-driven precision medicine solutions. The healthcare industry is expected to experience substantial growth in the future, driven by increasing demand for personalized healthcare and advancements in technology.

        

      Earnings Analysis: In the latest earnings report, Tempus AI reported a shortfall in both EPS and revenue. The reported EPS was -0.18, missing consensus estimates of -0.16 by -0.02. Revenue was $200.68M, which is a 35.8% increase compared to the previous year but fell short of the forecast by $2.44M. These misses have intensified selling pressure on the stock.

        

      Earnings Forecast: The earnings forecast for Tempus AI indicates expectations of future improvement. The company is projected to achieve revenue of $1.24B in FY25, incorporating synergies from Ambry Genetics. The forecasted EPS for FY25 is -0.67, which is expected to improve to 0.85 in FY27. It is important to note that these forecasts are subject to change and should be evaluated with caution.

        

      Technical Analysis: The support price for Tempus AI on February 24th was $47.26, while the resistance price was $69.66. The stock price on February 26th was $58.1095. This indicates that the stock is currently trading within the range of support and resistance levels.

        

      Analyst Recommendations: Currently, there are 2 recommendations, with 5 buy and 4 hold ratings for Tempus AI. Analysts have provided a target price range of $50.0 to $74.0, with a mean target price of $58.6.

        

      Capital Flow: In the past 5 days, there has been mixed capital flow for Tempus AI. On some days, there has been inflow, while on others, there has been outflow. It is important to consider the overall trend and volume of capital flow.

        

      News Impact: The recent bearish news regarding the earnings misses and revenue disappointment have had a significant impact on the stock price. The market reaction indicates increased selling pressure and skepticism from investors. It is important to monitor news developments and their impact on the stock.

        

      Please note that the above analysis is for informational purposes only and should not be considered as investment advice. The stock market carries inherent risks, and it is essential to do thorough research and consider individual risk tolerance before making any investment decisions.

      2025-02-26
      Reply
      Report
  • Hen Solo
    ·2025-02-26
    //@Barcode:

    📉📉📉🩸🩸🩸🇧 🇪 🇦 🇷 🇮 🇸 🇭 

    🚨📉💥 Tempus AI Plummets Post-Earnings, $43 Target Remains in Sight, Bearish Momentum Intensifies! 💥📉🚨

    “The market’s verdict is unequivocal, $TEM’s downward spiral was all but inevitable.”

    On 23Feb25, I forecasted a post-earnings decline for $TEM, and the market has delivered, shares cratered 14.04% in the after-hours session, now trading at $59.80. But the descent isn’t over, the trajectory to $43 remains wide open, signalling a prime opportunity for savvy bearish traders.

    💡 This isn’t a dip to buy, it’s a short seller’s utopia and a put option goldmine.

    📊 Tempus AI ($TEM) Q4 Earnings Dissection, Cracks Exposed Beneath the Surface:

    ❌ EPS Shortfall: Reported at -0.18, missing consensus estimates of -0.16 by -0.02

    ❌ Revenue Disappointment: $200.68M (+35.8% YoY), falling short of the $203.12M forecast by $2.44M

    🔻 After-Hours Collapse: $59.80, down 14.04%, as selling pressure mounts

    Despite FY25 revenue guidance of $1.24B (incorporating Ambry Genetics synergies), surpassing the $896.26M consensus, Wall Street remains sceptical. The dual misses on EPS and revenue have ignited a ferocious sell-off, with further downside looming large.

    🧮 Granular Financial Analysis, The Numbers Tell a Dire Story:

    • Adjusted EPS Loss: -0.18, narrowly better than the -0.20 estimate, but still mired in deficit

    • Reported EPS: -0.08, adjusted for one-time items, yet persistently negative

    • Revenue Gap: $200.68M, a $2.44M shortfall, underscoring execution challenges

    • Quarterly Net Loss: $13.01M, following a meteoric 101.7% share rally last quarter, a stark reversal

    💡 Even modest “beats” cloaked in red ink fail to inspire confidence on Wall Street, fuelling this aggressive bearish reaction.

    📉 Technical Catastrophe, Bearish Patterns Materialise with Precision:

    The rising wedge breakdown I flagged on 23Feb25 is unfolding with textbook precision. The post-earnings plunge validates the bearish thesis.

    • Resistance: $63, a formidable ceiling after the overnight rejection

    • Support Zones: Immediate target at $55, with $43 as the critical long-term downside objective

    • RSI: Plummeting below 40, firmly entrenched in bearish momentum territory

    • MACD: Bearish divergence cemented, foreshadowing sustained downward pressure

    💥 The chart’s structural integrity is shattered, the next bearish leg is imminent.

    🔥 Strategic Playbook, Sell, Short, and Deploy Puts, The Triple Bearish Assault:

    This isn’t a mere correction, it’s a systemic breakdown. Fundamentals are faltering, technicals are deteriorating, and market sentiment is shifting decisively!

    💡 Capitalise on rallies by shorting, leverage puts, and ride this bearish wave to $43.

    • Short Entry: Initiate below $60, aiming for $55, then the primary target of $43

    • Put Options Strategy: Target March 21 $55 puts, elevated implied volatility offers a compelling risk-reward profile for potential 2x-3x returns

    • Stop-Loss for Shorts: Set at $63 to mitigate risk during potential dead cat bounces

    • Profit-Taking Levels: Partially exit at $55, hold core positions for $43

    🗓 Market Sentiment, Analysts Clinging to Outdated Optimism:

    • Analyst Consensus: 🟢 7 Buy | 🟡 4 Hold | 🔴 0 Sell, stubbornly bullish despite the rout

    • Median Price Target: $55, already breached as the market accelerates lower

    • Short Interest: Surging, bearish momentum is gaining traction post-earnings

    💡 Wall Street’s lag in recalibrating targets contrasts sharply with the price action’s brutal honesty.

    🚀 Why $43 Is the Inevitable Magnet for $TEM:

    • Technical Breakdown: Collapsed support levels solidify the bearish outlook

    • Earnings Misses: Persistent shortfalls on both revenue and EPS amplify selling pressure

    • Sentiment Reversal: Insider selling prior to earnings, coupled with heightened retail pessimism, drives the decline

    • Volume Surge: Explosive post-earnings selling volume signals capitulation is underway

    💥 $43 isn’t merely a target, it’s the gravitational pull dragging $TEM downward.

    🎤 Trader’s Final Word, Seize the Opportunity:

    This is the moment to sell, short, and pile into puts. I predicted this decline, and I’m doubling down on the path to $43, don’t let this bearish opportunity slip away.

    @TigerGPT is $TEM poised for a complete collapse, or will bulls muster a fleeting bounce before the next leg lower?

    📢 Please Like, Engage, Share, and Follow for incisive setups, cutting-edge market insights, and high-probability trading strategies. Let’s conquer the markets together! 🍀

    Happy trading ahead! Cheers, BC 📈🚀🍀🍀🍀

    @Tiger_comments @TigerPicks @TigerWire @TigerStars @Daily_Discussion 

    Reply
    Report
    Fold Replies
    • TigerAI

      The recent plummet in the stock price of Tempus AI (TEM) is influenced by several factors. Here is the summary of the key points:

      Revenue Shortfall: Tempus AI reported revenue of $200.68 million in the fourth quarter of 2024, falling short of the forecasted $203.12 million by $2.44 million.

        

      EPS Shortfall: The earnings per share (EPS) was reported at -0.18, missing the consensus estimate of -0.16 by -0.02.

        

      After-Hours Collapse: The stock price experienced a significant decline, dropping 14.04% in the after-hours session and currently trading at $59.80.

        

      These factors have contributed to the bearish sentiment and intensified the downward momentum of TEM stock. As a result, the target price of $43 remains in sight, indicating a further potential decline.

      It's important to note that the information provided is for reference purposes only and should not be considered as investment advice. Investing in stocks involves risks, and it is recommended to conduct thorough research and analysis before making any investment decisions.

      For more detailed analysis and opinions on the earnings results of Tempus AI, I would suggest referring to relevant articles and reports from financial news sources.

      Please be cautious and consider consulting with a financial professional before making any investment decisions.

      Disclaimer: The above conclusion is for reference only and should not be considered as investment advice.

      2025-02-26
      Reply
      Report
    • TigerAI

      Stock Analysis: Tempus AI (TEM)

      Business and Industry: Tempus AI operates in the artificial intelligence industry, providing AI-based solutions for various sectors. The industry is expected to witness significant growth in the future as AI adoption increases across different domains.

        

      Latest Earnings and Earnings Forecast:

      Q4 2024 Earnings: Tempus AI reported an EPS of -0.08, with a negative return on equity (ROE) of -94.59%.  

      Earnings Forecast: For FY2025, the company is expected to have a negative EPS of -0.67, but the forecasted gross income is projected to reach 1.09 billion USD, with a forecasted EBIT of -70.21 million USD.  

        

      Recent Trends:

      Capital Flow (1 Day): The stock had a total inflow of 66.08 million USD and a total outflow of 50.91 million USD. The overall capital flow indicates relative stability.  

      Support and Resistance Prices (as of February 24, 2025):

      Support Price: 47.26 USD  

      Resistance Price: 69.66 USD  

      Current Stock Price (as of February 26, 2025): 58.87 USD  

        

        

      Analyst Viewpoints:

      Analyst Recommendation: 2 analysts recommend buying, 5 analysts rate the stock as a buy, and 4 analysts suggest holding the stock.  

      Target Price: The mean target price estimated by 10 analysts is 58.6 USD, with low and high target estimates of 50.0 USD and 74.0 USD, respectively.  

        

      Bullish and Bearish News: There are no specific bullish or bearish news articles available at the moment. The recent price decline in TEM stock may be attributed to stock capital flow.

        

      Disclaimer: The above analysis is for informational purposes only and should not be considered as investment advice. Investors should conduct their own research and analysis and evaluate the inherent risks in the stock market. Stock prices are subject to normal fluctuations, and investment decisions should be made independently.

        

      Please note that the information provided above is based on the available data and may not reflect real-time market conditions.

      2025-02-26
      Reply
      Report
  • Hen Solo
    ·2025-02-26
    //@Barcode:

    📉📉📉🩸🩸🩸🇧 🇪 🇦 🇷 🇮 🇸 🇭 

    🚨📉💥 Tempus AI Plummets Post-Earnings, $43 Target Remains in Sight, Bearish Momentum Intensifies! 💥📉🚨

    “The market’s verdict is unequivocal, $TEM’s downward spiral was all but inevitable.”

    On 23Feb25, I forecasted a post-earnings decline for $TEM, and the market has delivered, shares cratered 14.04% in the after-hours session, now trading at $59.80. But the descent isn’t over, the trajectory to $43 remains wide open, signalling a prime opportunity for savvy bearish traders.

    💡 This isn’t a dip to buy, it’s a short seller’s utopia and a put option goldmine.

    📊 Tempus AI ($TEM) Q4 Earnings Dissection, Cracks Exposed Beneath the Surface:

    ❌ EPS Shortfall: Reported at -0.18, missing consensus estimates of -0.16 by -0.02

    ❌ Revenue Disappointment: $200.68M (+35.8% YoY), falling short of the $203.12M forecast by $2.44M

    🔻 After-Hours Collapse: $59.80, down 14.04%, as selling pressure mounts

    Despite FY25 revenue guidance of $1.24B (incorporating Ambry Genetics synergies), surpassing the $896.26M consensus, Wall Street remains sceptical. The dual misses on EPS and revenue have ignited a ferocious sell-off, with further downside looming large.

    🧮 Granular Financial Analysis, The Numbers Tell a Dire Story:

    • Adjusted EPS Loss: -0.18, narrowly better than the -0.20 estimate, but still mired in deficit

    • Reported EPS: -0.08, adjusted for one-time items, yet persistently negative

    • Revenue Gap: $200.68M, a $2.44M shortfall, underscoring execution challenges

    • Quarterly Net Loss: $13.01M, following a meteoric 101.7% share rally last quarter, a stark reversal

    💡 Even modest “beats” cloaked in red ink fail to inspire confidence on Wall Street, fuelling this aggressive bearish reaction.

    📉 Technical Catastrophe, Bearish Patterns Materialise with Precision:

    The rising wedge breakdown I flagged on 23Feb25 is unfolding with textbook precision. The post-earnings plunge validates the bearish thesis.

    • Resistance: $63, a formidable ceiling after the overnight rejection

    • Support Zones: Immediate target at $55, with $43 as the critical long-term downside objective

    • RSI: Plummeting below 40, firmly entrenched in bearish momentum territory

    • MACD: Bearish divergence cemented, foreshadowing sustained downward pressure

    💥 The chart’s structural integrity is shattered, the next bearish leg is imminent.

    🔥 Strategic Playbook, Sell, Short, and Deploy Puts, The Triple Bearish Assault:

    This isn’t a mere correction, it’s a systemic breakdown. Fundamentals are faltering, technicals are deteriorating, and market sentiment is shifting decisively!

    💡 Capitalise on rallies by shorting, leverage puts, and ride this bearish wave to $43.

    • Short Entry: Initiate below $60, aiming for $55, then the primary target of $43

    • Put Options Strategy: Target March 21 $55 puts, elevated implied volatility offers a compelling risk-reward profile for potential 2x-3x returns

    • Stop-Loss for Shorts: Set at $63 to mitigate risk during potential dead cat bounces

    • Profit-Taking Levels: Partially exit at $55, hold core positions for $43

    🗓 Market Sentiment, Analysts Clinging to Outdated Optimism:

    • Analyst Consensus: 🟢 7 Buy | 🟡 4 Hold | 🔴 0 Sell, stubbornly bullish despite the rout

    • Median Price Target: $55, already breached as the market accelerates lower

    • Short Interest: Surging, bearish momentum is gaining traction post-earnings

    💡 Wall Street’s lag in recalibrating targets contrasts sharply with the price action’s brutal honesty.

    🚀 Why $43 Is the Inevitable Magnet for $TEM:

    • Technical Breakdown: Collapsed support levels solidify the bearish outlook

    • Earnings Misses: Persistent shortfalls on both revenue and EPS amplify selling pressure

    • Sentiment Reversal: Insider selling prior to earnings, coupled with heightened retail pessimism, drives the decline

    • Volume Surge: Explosive post-earnings selling volume signals capitulation is underway

    💥 $43 isn’t merely a target, it’s the gravitational pull dragging $TEM downward.

    🎤 Trader’s Final Word, Seize the Opportunity:

    This is the moment to sell, short, and pile into puts. I predicted this decline, and I’m doubling down on the path to $43, don’t let this bearish opportunity slip away.

    @TigerGPT is $TEM poised for a complete collapse, or will bulls muster a fleeting bounce before the next leg lower?

    📢 Please Like, Engage, Share, and Follow for incisive setups, cutting-edge market insights, and high-probability trading strategies. Let’s conquer the markets together! 🍀

    Happy trading ahead! Cheers, BC 📈🚀🍀🍀🍀

    @Tiger_comments @TigerPicks @TigerWire @TigerStars @Daily_Discussion 

    Reply
    Report
    Fold Replies
    • TigerAI

      The decline in Tempus AI (TEM) stock price on February 23, 2025, was primarily driven by a few factors:

      Earnings Miss: Tempus AI reported an EPS (Earnings Per Share) of -0.18, which missed the consensus estimate of -0.16 by -0.02. The company also fell short of revenue expectations, with $200.68 million, representing a 35.8% year-over-year growth, compared to the forecasted $203.12 million.

        

      Market Sentiment: Prior to the earnings announcement, there were instances of insider selling, combined with heightened retail pessimism, which contributed to the decline in sentiment and selling pressure.

        

      Technical Breakdown: The collapse of support levels further solidified the bearish outlook for the stock, indicating a technical breakdown in its price action.

        

      Volume Surge: There was an explosive surge in selling volume after the earnings announcement, suggesting that capitulation may be underway.

        

      It is important to note that there were no specific news articles or viewpoints available regarding the movement of Tempus AI stock on February 23, 2025.

      As for the target price of $43 mentioned in the post, it is crucial to conduct a thorough analysis and make investment decisions based on comprehensive research. While the post suggests a bearish stance, it is essential to consider potential risks and consult with a financial advisor before making any investment decisions.

      Please be aware that the information provided is for reference purposes only and does not constitute investment advice. Investing in stocks involves risks, including the potential loss of principal.

      2025-02-26
      Reply
      Report
    • TigerAI

      Based on the available information, here is an analysis of Tempus AI's (TEM) recent earnings:

      Earnings Data:

      Reported Period: 2024Q4  

      Earnings per Share (EPS) Shortfall: Reported at -0.18, missing consensus estimates of -0.16 by -0.02  

      Revenue Disappointment: $200.68 million (+35.8% YoY), falling short of the $203.12 million forecast by $2.44 million  

      Earnings Result:

      Previous Full Year (FY) Earnings: Reported EPS of -4.20, Return on Total Assets of -44.50%, Net Profit Margin of -40.26%  

      Quarterly Earnings (2024Q4): EPS of -0.08, Return on Total Assets of -1.75%, Net Profit Margin of -6.48%  

      Earnings Guidance:

      FY25 revenue guidance of $1.24 billion, incorporating Ambry Genetics synergies, surpassing the $896.26 million consensus  

      The disappointing earnings results, with a shortfall in EPS and revenue compared to expectations, have led to a significant sell-off of Tempus AI stock. As a result, the stock price has plummeted.

      However, it's important to note that the market's reaction to earnings is not always indicative of the long-term prospects of a company. While the earnings misses have raised concerns, the company's guidance for FY25 revenue suggests potential growth.

      It's worth considering the following scenarios:

      Swing Long (Risky): Watch for a potential bounce at $43-$45 if there is a positive earnings surprise, targeting $55.  

      Key Watch: If the stock price breaks below $55, a further decline to $43 is possible.  

      Options Play (Bearish): Consider March 21, 2025, $65 puts with an implied volatility of approximately 45%. If the stock price reaches $43, this options play could potentially yield 2x-3x returns.  

      It's important to note that these scenarios are purely speculative and based on the available information. Investing in the stock market involves risks, and it's recommended to conduct thorough research and consult with a financial advisor before making any investment decisions.

      Please note that the analysis provided is for reference purposes only and should not be considered as investment advice.

      2025-02-26
      Reply
      Report
  • Tui Jude
    ·2025-02-26
    //@Barcode:

    📉📉📉🩸🩸🩸🇧 🇪 🇦 🇷 🇮 🇸 🇭 

    🚨📉💥 Tempus AI Plummets Post-Earnings, $43 Target Remains in Sight, Bearish Momentum Intensifies! 💥📉🚨

    “The market’s verdict is unequivocal, $TEM’s downward spiral was all but inevitable.”

    On 23Feb25, I forecasted a post-earnings decline for $TEM, and the market has delivered, shares cratered 14.04% in the after-hours session, now trading at $59.80. But the descent isn’t over, the trajectory to $43 remains wide open, signalling a prime opportunity for savvy bearish traders.

    💡 This isn’t a dip to buy, it’s a short seller’s utopia and a put option goldmine.

    📊 Tempus AI ($TEM) Q4 Earnings Dissection, Cracks Exposed Beneath the Surface:

    ❌ EPS Shortfall: Reported at -0.18, missing consensus estimates of -0.16 by -0.02

    ❌ Revenue Disappointment: $200.68M (+35.8% YoY), falling short of the $203.12M forecast by $2.44M

    🔻 After-Hours Collapse: $59.80, down 14.04%, as selling pressure mounts

    Despite FY25 revenue guidance of $1.24B (incorporating Ambry Genetics synergies), surpassing the $896.26M consensus, Wall Street remains sceptical. The dual misses on EPS and revenue have ignited a ferocious sell-off, with further downside looming large.

    🧮 Granular Financial Analysis, The Numbers Tell a Dire Story:

    • Adjusted EPS Loss: -0.18, narrowly better than the -0.20 estimate, but still mired in deficit

    • Reported EPS: -0.08, adjusted for one-time items, yet persistently negative

    • Revenue Gap: $200.68M, a $2.44M shortfall, underscoring execution challenges

    • Quarterly Net Loss: $13.01M, following a meteoric 101.7% share rally last quarter, a stark reversal

    💡 Even modest “beats” cloaked in red ink fail to inspire confidence on Wall Street, fuelling this aggressive bearish reaction.

    📉 Technical Catastrophe, Bearish Patterns Materialise with Precision:

    The rising wedge breakdown I flagged on 23Feb25 is unfolding with textbook precision. The post-earnings plunge validates the bearish thesis.

    • Resistance: $63, a formidable ceiling after the overnight rejection

    • Support Zones: Immediate target at $55, with $43 as the critical long-term downside objective

    • RSI: Plummeting below 40, firmly entrenched in bearish momentum territory

    • MACD: Bearish divergence cemented, foreshadowing sustained downward pressure

    💥 The chart’s structural integrity is shattered, the next bearish leg is imminent.

    🔥 Strategic Playbook, Sell, Short, and Deploy Puts, The Triple Bearish Assault:

    This isn’t a mere correction, it’s a systemic breakdown. Fundamentals are faltering, technicals are deteriorating, and market sentiment is shifting decisively!

    💡 Capitalise on rallies by shorting, leverage puts, and ride this bearish wave to $43.

    • Short Entry: Initiate below $60, aiming for $55, then the primary target of $43

    • Put Options Strategy: Target March 21 $55 puts, elevated implied volatility offers a compelling risk-reward profile for potential 2x-3x returns

    • Stop-Loss for Shorts: Set at $63 to mitigate risk during potential dead cat bounces

    • Profit-Taking Levels: Partially exit at $55, hold core positions for $43

    🗓 Market Sentiment, Analysts Clinging to Outdated Optimism:

    • Analyst Consensus: 🟢 7 Buy | 🟡 4 Hold | 🔴 0 Sell, stubbornly bullish despite the rout

    • Median Price Target: $55, already breached as the market accelerates lower

    • Short Interest: Surging, bearish momentum is gaining traction post-earnings

    💡 Wall Street’s lag in recalibrating targets contrasts sharply with the price action’s brutal honesty.

    🚀 Why $43 Is the Inevitable Magnet for $TEM:

    • Technical Breakdown: Collapsed support levels solidify the bearish outlook

    • Earnings Misses: Persistent shortfalls on both revenue and EPS amplify selling pressure

    • Sentiment Reversal: Insider selling prior to earnings, coupled with heightened retail pessimism, drives the decline

    • Volume Surge: Explosive post-earnings selling volume signals capitulation is underway

    💥 $43 isn’t merely a target, it’s the gravitational pull dragging $TEM downward.

    🎤 Trader’s Final Word, Seize the Opportunity:

    This is the moment to sell, short, and pile into puts. I predicted this decline, and I’m doubling down on the path to $43, don’t let this bearish opportunity slip away.

    @TigerGPT is $TEM poised for a complete collapse, or will bulls muster a fleeting bounce before the next leg lower?

    📢 Please Like, Engage, Share, and Follow for incisive setups, cutting-edge market insights, and high-probability trading strategies. Let’s conquer the markets together! 🍀

    Happy trading ahead! Cheers, BC 📈🚀🍀🍀🍀

    @Tiger_comments @TigerPicks @TigerWire @TigerStars @Daily_Discussion 

    Reply
    Report
    Fold Replies
    • TigerAI

      根据现有的消息和数据,腾邦人工智能(TEM)近期股价下跌是由几个因素推动的:

      盈利令人失望:Tempus AI报告EPS(每股收益)缺口为-0.18,比市场普遍预期的-0.16低-0.02。该公司2.0068亿美元的营收也比预期低244万美元。

      市场情绪:市场对Tempus AI盈利的判断为负面,导致该股大幅抛售。看空势头加剧,导致股价大幅下跌。

      华尔街的怀疑:尽管该公司的2025财年收入指引超出了共识,但由于每股收益和收入的双重未达预期,华尔街仍然持怀疑态度。这进一步加剧了抛售,并引发了人们对该公司未来业绩的担忧。

      空头利息和期权交易:当前的市场状况为精明的看跌交易者提供了机会。对Tempus AI的空头兴趣正在攀升,表明越来越多的投资者押注该股进一步下跌。此外,如果该股达到43美元的目标价,看跌期权(例如2025年3月21日65美元的看跌期权,隐含波动率约为45%)可能会产生可观的回报。

      根据提供的信息,该股有可能跌至43美元,较当前价格下跌37%。然而,需要注意的是,投资股票存在风险,而且股市可能会波动。在做出任何投资决定之前,建议进行彻底的研究,评估您的风险承受能力,并考虑咨询财务顾问。

      请注意,所提供的信息仅供参考,不应被视为投资建议。

      2025-02-26
      Reply
      Report
    • TigerAI

      基于腾邦AI(TEM)的分析,以下是要点:

      商业和行业:腾邦人工智能在人工智能行业运营。随着各行业对人工智能技术需求的增加,该公司的业务预计将增长。

      盈利预测:2025财年,Tempus AI预计每股收益为-0.67美元,总收入为10.9亿美元。预计息税前利润为-7021万美元。预计该公司未来将改善其财务业绩,预计每股收益和总收入将增长。

      近期走势:该股近期支撑位47.26美元,阻力位69.66美元。该股目前的价格是59.1901美元。该股的获利比率为0.6122,表明存在潜在的获利机会。

      分析师推荐:在研究腾邦AI的十位分析师中,两位建议买入该股,五位建议持有,三位不推荐。分析师预估的平均目标价为58.6美元,最低预估为50.0美元,最高预估为74.0美元。

      资金流向:近五日,该股资金流向涨跌不一,有流入有流出。总流入和流出金额已经相对平衡。

      盈利结果:在上一季度(2024年第四季度),Tempus AI的每股收益为-0.08美元,股本回报率(ROE)为负-94.59%,毛利率为60.83%。该公司的财务比率表明存在一些财务挑战,例如负净利润率和负经营现金流与流动负债比率。

      考虑到上述信息,需要注意的是,腾邦人工智能股价近期的下跌趋势受到多种因素的影响,包括公司的盈利结果和市场情绪。这引起了投资者的担忧,并导致抛售压力。

      但是,考虑股票市场的内在风险和股票价格的正常波动是必不可少的。所提供的分析不应被视为投资建议。建议投资者在做出任何投资决定之前进行自己的研究并咨询财务顾问。

      2025-02-26
      Reply
      Report
  • Cool Cat Winston
    ·2025-02-24
    //@Sonsonkok:

    Great article, would you like to share it?

    Reply
    Report
  • Cool Cat Winston
    ·2025-02-24
    //@Tui Jude://@Kiwi Tigress:

    Great article, would you like to share it?

    Reply
    Report
  • Cool Cat Winston
    ·2025-02-24
    //@Hen Solo://@Sonsonkok

    很棒的文章,你愿意分享吗?

    Reply
    Report
  • Hen Solo
    ·2025-02-24
    //@Sonsonkok:

    Great article, would you like to share it?

    Reply
    Report
  • Tui Jude
    ·2025-02-24
    //@Kiwi Tigress:

    Great article, would you like to share it?

    Reply
    Report
  • PetS
    ·2025-02-24
    Great article, would you like to share it?
    Reply
    Report
  • CoffeeAndStocks
    ·2025-02-24

    Great article, would you like to share it?

    Reply
    Report
    Fold Replies
    • Barcode
      Happy trading ahead! Cheers BC 💰📈🚀🍀🍀🍀
      2025-02-24
      Reply
      Report
    • Barcode
      Happy trading ahead! Cheers BC 💰📈🚀🍀🍀🍀
      2025-02-24
      Reply
      Report
    • Barcode
      Have a great day! 🌞☀️🌞🍀🍀🍀
      2025-02-24
      Reply
      Report
    View more 1 comments
  • Sonsonkok
    ·2025-02-23

    Great article, would you like to share it?

    Reply
    Report
    Fold Replies
    • Barcode
      Happy trading ahead! Cheers BC 💰📈🚀🍀🍀🍀
      2025-02-23
      Reply
      Report
    • Barcode
      🙏🏼Thanks Sonsonkok! For sharing these market moves with the community and keeping us in sync with the momentum 🔥📈🚀🍀🍀🍀
      2025-02-23
      Reply
      Report
  • Hen Solo
    ·2025-02-23

    Great article, would you like to share it?

    Reply
    Report
    Fold Replies
    • Barcode
      🙏🏼 Grateful for the support HS! 📈🚀 These signals are carving paths through the charts and delivering market moves we love 🔥🍀🍀🍀
      2025-02-23
      Reply
      Report
  • Kiwi Tigress
    ·2025-02-23

    Great article, would you like to share it?

    Reply
    Report
    Fold Replies
    • Barcode
      🙏 Thanks for sharing. Much appreciated KT! These signals are catching sharp moves and lighting up the charts 🔥📊📈🍀🍀🍀
      2025-02-23
      Reply
      Report
    • Barcode
      😁💰💸Happy trading ahead! Cheers BC 💰📈🚀🍀🍀🍀
      2025-02-23
      Reply
      Report
    • Barcode
      🌞Have a great day! ☀️🌞☀️🍀🍀🍀
      2025-02-23
      Reply
      Report